Cardiac Rhythm Management (CRM) Devices Market to Surpass US$ 19,938.3 Mn by 2026, Boston Scientific Corporation and Medtronic Covers Majority of the Share: Fortune Business Insights Pune, July 01, 2019 (GLOBE NEWSWIRE) -- Technological advancements in cardiac rhythm devices are driving the global cardiac rhythm management devices market. Fortune Business Insights in a report,...

Integer Supports Respicardia’s Commercialization in the Central Sleep Apnea Market through Two New Agreements PLANO, Texas and MINNETONKA, Minn., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Integer, a leading medical device outsource (MDO) manufacturer, today announced it has entered into a new development agreement...